.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32
    Pub: 2006 Jun Epub:
    • Hütt P
    • Shchepetova J
    • Lõivukene K
    • Kullisaar T
    • Mikelsaar M

  2. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats.
    Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 1 Pages: 375-393
    Pub: 2019 Jan Epub: 2018 Oct 22
    • Li Y
    • Lv L
    • Ye J
    • Fang D
    • Shi D
    • Wu W
    • Wang Q
    • Wu J
    • Yang L
    • Bian X
    • Jiang X
    • Jiang H
    • Yan R
    • Peng C
    • Li L

  3. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21
    Pub: 2015 Apr Epub:
    • Shadnoush M
    • Hosseini RS
    • Khalilnezhad A
    • Navai L
    • Goudarzi H
    • Vaezjalali M

  4. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.
    The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
    Pub: 2018 Sep Epub: 2018 May 28
    • Xia X
    • Chen J
    • Xia J
    • Wang B
    • Liu H
    • Yang L
    • Wang Y
    • Ling Z

  5. Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.
    World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704
    Pub: 2017 Apr 21 Epub:
    • Toscano M
    • De Grandi R
    • Stronati L
    • De Vecchi E
    • Drago L

  6. Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial.
    International journal of obesity (2005) (Int J Obes (Lond) ) Vol: Issue Pages:
    Pub: 2018 Sep 27 Epub: 2018 Sep 27
    • Pedret A
    • Valls RM
    • Calderón-Pérez L
    • Llauradó E
    • Companys J
    • Pla-Pagà L
    • Moragas A
    • Martín-Luján F
    • Ortega Y
    • Giralt M
    • Caimari A
    • Chenoll E
    • Genovés S
    • Martorell P
    • Codoñer FM
    • Ramón D
    • Arola L
    • Solà R

  7. Additional sources and private correspondance
    Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12
    Pub: 2018 Epub:
  8. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-?B activation through restoration of the disturbed gut microbiota.
    Food & function (Food Funct ) Vol: 9 Issue 8 Pages: 4255-4265
    Pub: 2018 Aug 15 Epub:
    • Kim WG
    • Kim HI
    • Kwon EK
    • Han MJ
    • Kim DH

  9. Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-?B activation and lipopolysaccharide production by gut microbiota.
    Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 41 Issue Pages: 86-96
    Pub: 2017 May Epub: 2017 Apr 19
    • Lim SM
    • Kim DH

  10. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
    International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 42 Issue 6 Pages: 475-81
    Pub: 2013 Dec Epub: 2013 Sep 7
    • Sikorska H
    • Smoragiewicz W

Full list available by paid subscriptions

For More information see this summary.